Treatment with dasatinib, a highly potent BCR-ABL kinase inhibitor, has resulted in high rates of complete cytogenetic response and progression-free survival among patients with chronic myeloid ...

We evaluated dasatinib, a BCR-ABL inhibitor that targets most imatinib-resistant BCR-ABL mutations, in patients with chronic myelogenous leukemia (CML) or Ph-positive acute lymphoblastic leukemia ...

MADRID — Dasatinib (Sprycel, Bristol-Myers Squibb) has shown efficacy and safety in children similar to those already demonstrated in adults with chronic myeloid leukemia in the chronic phase ...

You may hear this called Philadelphia positive leukaemia. Dasatinib is a type cancer growth blocker called a tyrosine kinase inhibitor. It works by blocking a signal that tells leukaemia cells to grow ...

For a general overview of Sprycel, including details about its uses, see this article. Sprycel (dasatinib) can cause certain side effects, some of which are more common than others. These side ...

Dasatinib is a cancer drug, sold under the name Sprycel® to treat certain types of leukemia in adults and children. Its side effects include low blood cell counts, anemia, rash, and diarrhea. It may ...

120 (1). While Tyrosine Kinase Inhibitors (TKI), including dasatinib, have profoundly improved clinical outcomes in patients with chronic myeloid leukemia (CML), the bioavailability and systematic ...

A new research paper titled "Exploring the effects of dasatinib, quercetin, and fisetin on DNA methylation clocks: a longitudinal study on senolytic interventions" has been published in Aging.

Investigators have found that dasatinib, a drug commonly used to treat chronic myeloid leukemia, is strongly associated with kidney injury. The study team strongly believes this study will impact ...

You may hear this called Philadelphia positive leukaemia. Dasatinib is a type cancer growth blocker called a tyrosine kinase inhibitor. It works by blocking a signal that tells leukaemia cells to grow ...